Integrated modelling of the clinical pharmacokinetics of SDZ HTF 919, a novel selective 5-HT(4)receptor agonist, following oral and intravenous administration

AIMS: The purpose of the present study was to assess the pharmacokinetics of the novel selective 5-HT(4) receptor agonist SDZ HTF 919 (HTF) including food effect, absolute bioavailability, interoccasion and intersubject variabilities. METHODS: In the randomized, open-label, three treatment, four per...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Appel-Dingemanse, Silke, Lemarechal, Marie-Odile, Kumle, Anette, Hubert, Martine, Legangneux, Eric
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Blackwell Science Inc 1999
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2014177/
https://ncbi.nlm.nih.gov/pubmed/10336571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.1999.00936.x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg